Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Hum Mutat. 2018 Nov;39(11):1593–1613. doi: 10.1002/humu.23630

Table 5b:

Recommendation for determining the appropriate ACMG/AMP evidence strength level for de novo occurrence(s)

Supporting
(PS2_Supporting or
PM6_Supporting)
Moderate
(PS2_Moderate or
PM6)
Strong
(PS2 or
PM6_Strong)
Very Strong
(PS2_VeryStrong or
PM6_VeryStrong)
0.5 points 1.0 points 2.0 points 4.0 points